INST2ANT-HF

• Research type

  Research Study

• Full title

  Investigating the soluble ST2 biomarker in addition to Natriuretic peptides in managing patients with Heart Failure and a Reduced Ejection Fraction (INST2ANT-HF)

• IRAS ID

  268762

• Contact name

  Henry Oluwasefunmi Savage

• Contact email

  henry.savage@btuh.nhs.uk

• Sponsor organisation

  Basildon and Thurrock University Hospitals NHS Foundation Trust

• Duration of Study in the UK

  1 years, 0 months, days

• Research summary

  We intend to study the soluble ST2 (sST2) biomarker to determine its clinical relevance in managing a broad cohort of real-world patients with Heart Failure and a reduced ejection Fraction receiving contemporary therapies.

  This study would provide real-world observational data on the additive risk stratification value of the sST2 biomarker in the management of these patients, to that of natriuretic peptides.

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  19/EE/0269

• Date of REC Opinion

  1 Oct 2019

• REC opinion

  Further Information Favourable Opinion